Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Alliqua BioMedical Inc (ALQA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011376
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s product categories include ultrasound healing therapy, human biologics, antimicrobial protection, and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market. Alliqua BioMedical develops and manufactures electron-beam cross-linked sheet gels for manufacturer of medical devices, cosmeceuticals, and other commercial product applications. The company’s customer service professionals assist with order placement, product training, and reimbursement. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.

Alliqua BioMedical Inc (ALQA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Alliqua BioMedical Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Choice Therapeutics Secures US$0.6 Million In Financing 12
Partnerships 13
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 13
Alliqua Enters Into Distribution Agreement With Sorbion 14
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 15
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 16
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 17
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 18
Equity Offering 19
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 19
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 21
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 22
Alliqua Completes Private Placement Of Shares For US$15 Million 24
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 25
Alliqua Completes Private Placement Of Shares For US$6 Million 26
Alliqua Completes Private Placement Of Units For US$1 Million 28
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 29
Alliqua Completes Private Placement Of Shares For US$0.8 Million 30
Alliqua Completes Private Placement Of Units For US$0.3 Million 31
Alliqua Completes Private Placement Of Units For US$1.7 Million 32
Alliqua Completes Private Placement Of US$1 Million 33
Alliqua Completes Private Placement Of Shares For US$0.4 Million 34
Asset Transactions 35
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 35
Acquisition 36
Alliqua BioMedical Acquires Celleration for USD46.3 Million 36
Alliqua BioMedical Inc – Key Competitors 37
Alliqua BioMedical Inc – Key Employees 38
Alliqua BioMedical Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Nov 09, 2017: Alliqua BioMedical Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook 40
Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 43
May 09, 2017: Alliqua BioMedical Reports First Quarter of Fiscal Year 2017 Financial Results 45
Apr 06, 2017: Alliqua BioMedical Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017 Outlook 46
Mar 07, 2017: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2016 Financial Results 47
Nov 04, 2016: Alliqua BioMedical Reports Third Quarter and Nine-Months Fiscal Year 2016 Financial Results 50
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue 52
Oct 05, 2016: Alliqua BioMedical Announces Preliminary Third Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for November 4th 53
Aug 09, 2016: Alliqua BioMedical Reports Second Quarter and Six Months Fiscal Year 2016 Financial Results 54
Jul 07, 2016: Alliqua BioMedical Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue 56
May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 57
Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 59
Corporate Communications 61
Feb 19, 2016: Alliqua BioMedical Announces Changes to Its Board of Directors 61
Other Significant Developments 62
Nov 09, 2017: Alliqua BioMedical Engages Cowen to Assist in Evaluating Potential Strategic Alternatives 62
Sep 05, 2017: Alliqua BioMedical Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Alliqua BioMedical Inc, Medical Equipment, Key Facts, 2016 2
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Alliqua BioMedical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Alliqua BioMedical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Alliqua BioMedical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Alliqua BioMedical Inc, Deals By Market, 2011 to YTD 2017 9
Alliqua BioMedical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Choice Therapeutics Secures US$0.6 Million In Financing 12
BSN medical to Enter into Distribution Agreement with Alliqua BioMedical 13
Alliqua Enters Into Distribution Agreement With Sorbion 14
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 15
Alliqua BioMedical Amends Licensing Agreement with Celgene Cellular Therapeutics 16
Alliqua Enters Into Licensing Agreement With Noble Biomaterials 17
Alliqua Enters Into Licensing Agreement With Celgene Cellular Therapeutics For Wound Care Products 18
Alliqua BioMedical Raises USD3.8 Million in Public Offering of Shares 19
Alliqua BioMedical Raises USD2.8 Million in Private Placement of Shares 21
Alliqua BioMedical Completes Public Offering of Shares for USD34.5 Million 22
Alliqua Completes Private Placement Of Shares For US$15 Million 24
Alliqua Completes Private Placement Of Shares For US$5.3 Million Upon Exercise Of Warrants 25
Alliqua Completes Private Placement Of Shares For US$6 Million 26
Alliqua Completes Private Placement Of Units For US$1 Million 28
Alliqua Completes Final Tranche Of Private Placement Of Shares For US$2 Million 29
Alliqua Completes Private Placement Of Shares For US$0.8 Million 30
Alliqua Completes Private Placement Of Units For US$0.3 Million 31
Alliqua Completes Private Placement Of Units For US$1.7 Million 32
Alliqua Completes Private Placement Of US$1 Million 33
Alliqua Completes Private Placement Of Shares For US$0.4 Million 34
Argentum Medical Acquires TheraBond and TheraBond 3D Antimicrobial Barrier Systems from Alliqua BioMedical for USD3.8 Million 35
Alliqua BioMedical Acquires Celleration for USD46.3 Million 36
Alliqua BioMedical Inc, Key Competitors 37
Alliqua BioMedical Inc, Key Employees 38
Alliqua BioMedical Inc, Subsidiaries 39

★海外企業調査レポート[Alliqua BioMedical Inc (ALQA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Denka Co Ltd (4061):企業の財務・戦略的SWOT分析
    Denka Co Ltd (4061) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Dominion Energy Inc (D):電力:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Smurfit Kappa Group plc:企業のM&A・事業提携・投資動向
    Smurfit Kappa Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smurfit Kappa Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Airgas Inc:企業の戦略的SWOT分析
    Airgas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Sisaf Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • Qatar Electricity & Water Co QPSC (QEWS):電力:M&Aディール及び事業提携情報
    Summary Qatar Electricity & Water Co QPSC (QEWC), formerly Qatar Electricity & Water Company QSC, is an electricity and water utility. It generates electricity and desalinates water. The company owns and operates various power generation and water desalination stations and substations primarily in Q …
  • GW Pharmaceuticals Plc (GWPH):医療機器:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Bank AlJazira:企業の戦略・SWOT・財務情報
    Bank AlJazira - Strategy, SWOT and Corporate Finance Report Summary Bank AlJazira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Acona Holding AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Acona Holding AS (Acona) is an oil and gas company that offers well management and cleaning technology services. The company’s services include drilling and well technology services, exploration and production technology, field development, and oil and gas consulting services. It also provid …
  • TTEC Holdings Inc (TTEC):企業の財務・戦略的SWOT分析
    TTEC Holdings Inc (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vestas Wind Systems A/S:企業の戦略・SWOT・財務分析
    Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report Summary Vestas Wind Systems A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nishat Mills Ltd:企業の戦略・SWOT・財務情報
    Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report Summary Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fuji Pharma Co Ltd (4554):企業の財務・戦略的SWOT分析
    Summary Fuji Pharma Co Ltd (Fuji Pharma) develops, manufactures, and commercializes pharmaceutical products. The company specializes in offering injection agents, drugs for external use, internal drugs, and diagnostic products among others. It also provides medical care products for women, acute med …
  • SAS AB:企業の戦略・SWOT・財務情報
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Houlihan Lokey Inc (HLI):企業の財務・戦略的SWOT分析
    Summary Houlihan Lokey Inc (Houlihan) is an investment bank. It provides corporate finance, financial advisory, financial restructuring and strategic consulting services. The bank’s corporate finance services include mergers and acquisitions, capital markets, private fund advisory and board advisory …
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆